09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Free Paper: Refractive Surgery<br />

Sun 19 Feb 15:30 - 17:00 Capital Suite 10<br />

FP-REF-SU 344 (1)<br />

Scotopic Measurement <strong>of</strong> Normal Pupils Pre-Refractive Surgery<br />

Alharbi Faisal (1) , Rushood Adel (2) , Alobeidan Abdulaziz (3)<br />

1. Military Hospital, Dhahran<br />

2. King Fahad Hospital<br />

3. Military Hospital<br />

Purpose: To find out the scotopic pupil size in normal patients coming for<br />

refractive surgery.<br />

Methods: A prospective study <strong>of</strong> the pupil size <strong>of</strong> 100 consecutive Saudi<br />

patients (34 females and 66 males) with a mean age <strong>of</strong> 29.83 years scheduled<br />

for refractive surgery in Kahhal eye Center from March 2003 to May 2003 using<br />

hand-held pupillometer.<br />

Results: Mean scotopic pupil diameter was 6.37mm ± 0.86 (SD) (range 4.0-9.0<br />

mm). Mean scotopic pupil diameter for females was 6.08mm ± 0.83(SD)<br />

(range 4.1-7.8 mm). Mean scotopic pupil diameter for male was 6.51mm ±<br />

0.84(SD) (range 4.0-9.0 mm). Mean scotopic pupil diameter for the right eye<br />

was 6.33mm ± 0.87 (SD) (range 4.1-8.6 mm). Mean sctopic pupil diameter<br />

for the left eye was 6.40mm ± 0.88 (SD) (range 4.0-9.0 mm). Only eighteen<br />

patients (18%) had identical pupils.<br />

Conclusion: A mean scotopic pupil size <strong>of</strong> 6.37mm with a maximal pupil size <strong>of</strong><br />

9.0mm can be expected in our patients. Few patients have identical pupils.<br />

Patients with large pupils should be counseled about the high risk <strong>of</strong> glare and<br />

halos or the selection <strong>of</strong> a larger ablation.<br />

FP-REF-SU 344 (2)<br />

Comparison <strong>of</strong> Asphericity and Spherical Aberration Changes in<br />

Wavefront Guided (WFG) versus Aspheric WFG LASEK Treatment <strong>of</strong><br />

Myopic Astigmatism<br />

Hashemian Seyed Javad (1)<br />

1. Eye Reaserch Center,Rasoul Akram Hospital,Tehran Uneversity <strong>of</strong> Medical<br />

Sciences<br />

Purpose: To evaluate the asphericity and spherical aberration (SA) changes in<br />

patient with myopic astigmatism treated with WFG versus aspheric WFG<br />

LASEK.<br />

Methods: A prospective case control study <strong>of</strong> 115 eyes with myopic astigmatism<br />

designed in two groups; 58 eyes were treated with WFG and 57 eyes with<br />

aspheric WFG LASEK (Zyoptix, APT). Pre and post operative refraction,<br />

UCDVA, CDVA, amount <strong>of</strong> Q value and higher order aberration changes were<br />

evaluated.<br />

Results: Pre operative MRSE was -3.32± 1.25 D and mean cylinder was -0.74<br />

± 0.82 D in WFG group and -3.23 ± 1.13 D and – 0.95 ± 0.80 D in aspheric<br />

group respectively. At 12 months MRSE was + 0.17± 0.21 and + 0.27 ± 0.40<br />

respectively. At 12 months Q value increase from-0.185 to 0.394µm in WFG<br />

group and from -0.191 to 0.225 µm in aspheric group (P=0.009).Pre Op mean<br />

SA in WFG group was – 0.029 ± 0.09 ?m and in aspheric group -0.031 ±0.130,<br />

at 12 months was – 0.223 ± 0.17 and -0.112±0.169 respectively (P=0.001).<br />

Conclusions: Our study demonstrates that aspheric WFG LASEK in treatment<br />

<strong>of</strong> myopic astigmatism is an effective and safe and induce lower amount <strong>of</strong> SA<br />

and corneal oblation.<br />

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

FP-REF-SU 344 (3)<br />

Prevalence <strong>of</strong> Emmetropia Among Cases <strong>of</strong> Combined PRK and<br />

Crosslinking in Treatment <strong>of</strong> Keratoconus<br />

Al-Tuwairqi Waleed (1)<br />

1. Elite Medical and Surgical Center<br />

Purpose: To evaluate the incidence <strong>of</strong> over and under correction following<br />

combined PRK and crosslinking surgery in keratoconus patients.<br />

Methods: Retrospective study. 100 eyes were included in the study with<br />

moderate degree <strong>of</strong> keratoconus that underwent combined PRK and<br />

crosslinking in the last 3 years with regular follow up and with no further<br />

intervention for keratoconus treatment. Pre and post operative evaluation <strong>of</strong><br />

visual acuity, refraction, corneal topography and patient satisfaction.<br />

Results: Preliminary assessment <strong>of</strong> the results showed a significant prevalence<br />

<strong>of</strong> hypermetropia (over correction) among cases <strong>of</strong> PRK and crosslinking<br />

which requires further statistical analysis.<br />

Conclusion: Although emmetropia is planned, all cases underwent combined<br />

PRK and crosslinking. It was not achieved in a significant number <strong>of</strong> patients<br />

which will entail further adjustment <strong>of</strong> the current nomograms.<br />

FP-REF-SU 344 (4)<br />

Wavefront-Guided PRK for Forme Fruste Keratoconus: 3 Years<br />

Results<br />

Shafik Shaheen Mohamed (1)<br />

1. Pr<strong>of</strong>essor <strong>of</strong> Opthalmology, University <strong>of</strong> Alexandria<br />

To evaluate the safety and efficacy <strong>of</strong> the Wavefront-guide photokeratectomy<br />

in refractive correction <strong>of</strong> the eyes with forme fruste keratoconus (KCFF)<br />

Prospective study for 33 eyes (19 patients) having KCFF. All eyes were treated<br />

by Wavefront-guided PRK with adjunctive mitomycin-C using VISX Star S4<br />

Excimer Laser. Patients were selected according to the inclusion criteria <strong>of</strong> the<br />

ectasia committee <strong>of</strong> ASCRS, ESCRS and AAO. Patients were followed up for<br />

more than 36 months. Patients mean age was 32.6 ± 5.3 years (26 – 42 years).<br />

Their mean cycloplegic refraction was -3.67 ± 1.62 D (-2.50 to - 5.50D). The<br />

preoperative BCVA was 0.93 ± 0.17 (0.8 - 1.2). Mean preoperative pachymetry<br />

was 497 ± 35 µm (460 - 535 µm). Mean ablation depth was 63 ± 13 µm (45 - 75<br />

µm). Mean follow up period was 30 ± 5.4 months (27-39 months). Mean UCVA<br />

was 0.90 ± 0.14 (0.8 -1.2). No single case <strong>of</strong> ectasia was reported.) Wavefront<br />

guided PRK is an effective and safe technique for correction <strong>of</strong> refractive errors<br />

in cases <strong>of</strong> forme fruste keratoconus. The inclusion criteria for these cases<br />

suggested by the ectasia committee seem to be enough to guard against<br />

possible complications.<br />

FP-REF-SU 344 (5)<br />

Evaluation <strong>of</strong> the SUPRACOR Technique on the Technolas 217P<br />

Excimer Laser for Presbyopic Hyperopia: First Preliminary Results<br />

in Jordan<br />

Alsamady Suhaib (1)<br />

1. Ibn Al Haytham Hospital<br />

Purpose: To analyze the outcomes <strong>of</strong> the SUPRACOR algorithm when treating<br />

hyperopic presbyopic patients.<br />

Methods: Two sequential groups <strong>of</strong> hyperopic presbyopic patients were treated<br />

binocularly with SUPRACOR on the Technolas 217P excimer laser (Technolas<br />

Perfect Vision). In Group 1 (6 patients), mean age was 51.7±1.8 years (range:<br />

47-56), with hyperopia <strong>of</strong> +2.0±0.6 Diopters (D) (range:+1.25 to +3), cylinder <strong>of</strong><br />

-0.5 ± 0.3D (range:-0.25 to -1.25), and near addition <strong>of</strong> +2.0±0.3D (range:+1.75<br />

to +2.25). Follow-up was at 1 week, 3, 6 and 12 months.<br />

Results: Six months postoperatively for Group 1, the mean monocular<br />

uncorrected distance visual acuity (UDVA) was 0.8±0.13 (Range: 0.63–1.0)<br />

and near vision was Jaeger (J) 1.125±0.3 (range: J2 – J1+). Mean Spherical<br />

Equivalent Refraction was -0.57±0.26D (range:-0.125 to -1). 100% achieved<br />

monocular UDVA <strong>of</strong> 0.63 or better, 83% were 0.8 or more. 100% had<br />

monocular uncorrected near visual acuity <strong>of</strong> J2 or better, with 83.3% at J1 or<br />

better. Further data on Group 2 patients will also be presented.<br />

Conclusions: SUPRACOR is safe and efficient, providing improved near vision,<br />

while maintaining good distance vision. Patients are happy with their vision at<br />

all distances. No re-treatments have been required during 6 months follow-up<br />

329

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!